Statute

§90‑87. Definitions.As used in this Article:(1) “Administer” means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means to the body of a patient or research subject by:a. A practitioner (or, in his presence, by his authorized agent), orb. The patient or research subject at the direction and in the presence of the practitioner.(2) “Agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser but does not include a common or contract carrier, public warehouseman, or employee thereof.(3) “Bureau” means the Bureau of Narcotics and Dangerous Drugs, United States Department of Justice or its successor agency.(3a) “Commission” means the Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services established under Part 4 of Article 3 of Chapter 143B of the General Statutes.(4) “Control” means to add, remove, or change the placement of a drug, substance, or immediate precursor included in Schedules I through VI of this Article.(5) “Controlled substance” means a drug, substance, or immediate precursor included in Schedules I through VI of this Article.(5a) “Controlled substance analogue” means a substance (i) the chemical structure of which is substantially similar to the chemical structure of a controlled substance in Schedule I or II; (ii) which has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; or (iii) with respect to a particular person, which such person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; and does not include (i) a controlled substance; (ii) any substance for which there is an approved new drug application; (iii) with respect to a particular person any substance, if an exemption is in effect for investigational use, for that person, under § 355 of Title 21 of the United States Code to the extent conduct with respect to such substance is pursuant to such exemption; or (iv) any substance to the extent not intended for human consumption before such an exemption takes effect with respect to that substance. The designation of gamma butyrolactone or any other chemical as a listed chemical pursuant to subdivision 802(34) or 802(35) of Title 21 of the United States Code does not preclude a finding pursuant to this subdivision that the chemical is a controlled substance analogue.(6) “Counterfeit controlled substance” means:a. A controlled substance which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number, or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person or persons who in fact manufactured, distributed, or dispensed such substance and which thereby falsely purports, or is represented to be the product of, or to have been distributed by, such other manufacturer, distributor, or dispenser; orb. Any substance which is by any means intentionally represented as a controlled substance. It is evidence that the substance has been intentionally misrepresented as a controlled substance if the following factors are established:1. The substance was packaged or delivered in a manner normally used for the illegal delivery of controlled substances.2. Money or other valuable property has been exchanged or requested for the substance, and the amount of that consideration was substantially in excess of the reasonable value of the substance.3. The physical appearance of the tablets, capsules or other finished product containing the substance is substantially identical to a specified controlled substance.(7) “Deliver” or “delivery” means the actual constructive, or attempted transfer from one person to another of a controlled substance, whether or not there is an agency relationship.(8) “Dispense” means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.(9) “Dispenser” means a practitioner who dispenses.(10) “Distribute” means to deliver other than by administering or dispensing a controlled substance.(11) “Distributor” means a person who distributes.(12) “Drug” means a. substances recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; b. substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; c. substances (other than food) intended to affect the structure or any function of the body of man or other animals; and d. substances intended for use as a component of any article specified in a, b, or c of this subdivision; but does not include devices or their components, parts, or accessories.(13) “Drug dependent person” means a person who is using a controlled substance and who is in a state of psychic or physical dependence, or both, arising from use of that controlled substance on a continuous basis. Drug dependence is characterized by behavioral and other responses which include a strong compulsion to take the substance on a continuous basis in order to experience its psychic effects, or to avoid the discomfort of its absence.(14) “Immediate precursor” means a substance which the Commission has found to be and by regulation designates as being the principal compound commonly used or produced primarily for use, and which is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail, or limit such manufacture.(14a) The term “isomer” means, except as used in G.S. 90‑87(17)(d), G.S. 90‑89(c), G.S. 90‑90(1)d., and G.S. 90‑95(h)(3), the optical isomer. As used in G.S. 90‑89(c) the term “isomer” means the optical, position, or geometric isomer. As used in G.S. 90‑87(17)(d), G.S. 90‑90(1)d., and G.S. 90‑95(h)(3) the term “isomer” means the optical isomer or diastereoisomer.(15) “Manufacture” means the production, preparation, propagation, compounding, conversion, or processing of a controlled substance by any means, whether directly or indirectly, artificially or naturally, or by extraction from substances of a natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis; and “manufacture” further includes any packaging or repackaging of the substance or labeling or relabeling of its container except that this term does not include the preparation or compounding of a controlled substance by an individual for his own use or the preparation, compounding, packaging, or labeling of a controlled substance:a. By a practitioner as an incident to his administering or dispensing of a controlled substance in the course of his professional practice, orb. By a practitioner, or by his authorized agent under his supervision, for the purpose of, or as an incident to research, teaching, or chemical analysis and not for sale.(16) “Marijuana” means all parts of the plant of the genus Cannabis, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber produced from such stalks, oil, or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination.(17) “Narcotic drug” means any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:a. Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate.b. Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in clause a, but not including the isoquinoline alkaloids of opium.c. Opium poppy and poppy straw.d. Cocaine and any salt, isomer, salts of isomers, compound, derivative, or preparation thereof, or coca leaves and any salt, isomer, salts of isomers, compound, derivative or preparation of coca leaves, or any salt, isomer, salts of isomers, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocanized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.(18) “Opiate” means any substance having an addiction‑forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction‑forming or addiction‑sustaining liability. It does not include, unless specifically designated as controlled under G.S. 90‑88, the dextrorotatory isomer of 3‑methoxy‑n‑methyl‑morphinan and its salts (dextromethorphan). It does include its racemic and levorotatory forms.(19) “Opium poppy” means the plant of the species Papaver somniferum L., except its seeds.(20) “Person” means individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.(21) “Poppy straw” means all parts, except the seeds, of the opium poppy, after mowing.(22) “Practitioner” means:a. A physician, dentist, optometrist, veterinarian, scientific investigator, or other person licensed, registered or otherwise permitted to distribute, dispense, conduct research with respect to or to administer a controlled substance so long as such activity is within the normal course of professional practice or research in this State.b. A pharmacy, hospital or other institution licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to or to administer a controlled substance so long as such activity is within the normal course of professional practice or research in this State.(23) “Prescription” means:a. A written order or other order which is promptly reduced to writing for a controlled substance as defined in this Article, or for a preparation, combination, or mixture thereof, issued by a practitioner who is licensed in this State to administer or prescribe drugs in the course of his professional practice; or issued by a practitioner serving on active duty with the armed forces of the United States or the United States Veterans Administration who is licensed in this or another state or Puerto Rico, provided the order is written for the benefit of eligible beneficiaries of armed services medical care; a prescription does not include an order entered in a chart or other medical record of a patient by a practitioner for the administration of a drug; orb. A drug or preparation, or combination, or mixture thereof furnished pursuant to a prescription order.(24) “Production” includes the manufacture, planting, cultivation, growing, or harvesting of a controlled substance.(25) “Registrant” means a person registered by the Commission to manufacture, distribute, or dispense any controlled substance as required by this Article.(26) “State” means the State of North Carolina.(27) “Ultimate user” means a person who lawfully possesses a controlled substance for his own use, or for the use of a member of his household, or for administration to an animal owned by him or by a member of his household.

G.S. 90-88 is not reproduced here.

§90‑89. Schedule I controlled substances.This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a high potential for abuse, no currently accepted medical use in the United States, or a lack of accepted safety for use in treatment under medical supervision. The following controlled substances are included in this schedule:(1) Any of the following opiates, including the isomers, esters, ethers, salts and salts of isomers, esters, and ethers, unless specifically excepted, or listed in another schedule, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:a. Acetyl‑alpha‑methylfentanyl (N[1‑(1‑methyl‑2‑phenethyl)‑4‑ piperidinyl]‑N‑phenylacetamide).b. Acetylmethadol.c. Repealed by Session Laws 1987, c. 412, s. 2.d. Alpha‑methylthiofentanyl N‑[1‑methyl‑2‑(2‑thienyl) ethyl‑4‑piperidinyl]‑N‑phenylpropanamide).e. Allylprodine.f. Alphacetylmethadol.g. Alphameprodine.h. Alphamethadol.i. Alpha‑methylfentanyl (N‑(1‑(alpha‑methyl‑beta‑phenyl) ethyl‑4‑piperidyl) propionalilide; 1(1‑methyl‑2‑phenyl‑ethyl)‑4‑(N‑propanilido) piperidine).j. Benzethidine.k. Betacetylmethadol.l. Beta‑hydroxfentanyl (N‑[1‑(2‑hydroxy‑2‑phenethyl)‑4‑piperidinyl]‑N‑ phenylpropanamide).m. Beta‑hydroxy‑3‑methylfentanyl (N‑[1‑(2‑hydroxy‑2‑phenethyl)‑3‑ methyl‑4‑piperidinyl]‑N‑phenylpropanamide).n. Betameprodine.o. Betamethadol.p. Betaprodine.q. Clonitazene.r. Dextromoramide.s. Diampromide.t. Diethylthiambutene.u. Difenoxin.v. Dimenoxadol.w. Dimepheptanol.x. Dimethylthiambutene.y. Dioxaphetyl butyrate.z. Dipipanone.aa. Ethylmethylthiambutene.bb. Etonitazene.cc. Etoxeridine.dd. Furethidine.ee. Hydroxypethidine.ff. Ketobemidone.gg. Levomoramide.hh. Levophenacylmorphan.ii. 1‑methyl‑4‑phenyl‑4‑propionox ypiperidine (MPPP).jj. 3‑Methylfentanyl (N‑[3‑methyl‑1‑(2‑Phenylethyl)‑4‑Pi‑peridyl]‑N‑Phenylpropanamide).kk. 3‑Methylthiofentanyl (N‑[(3‑methyl‑1‑(2‑thienyl)ethyl‑4‑piperidinyl]‑N‑phenylpropa namide).ll . Morpheridine.mm. Noracymethadol.nn. Norlevorphanol.oo. Normethadone.pp. Norpipanone.qq. Para‑fluorofentanyl (N‑(4‑fluorophenyl)‑N‑[1‑(2‑phen‑ethyl)‑4‑ piperidinyl]‑propanamide.rr. Phenadoxone.ss. Phenampromide.tt. 1‑(2‑phenethyl)‑4‑phenyl‑4‑acetoxypiperidine (PEPAP).uu. Phenomorphan.vv. Phenoperidine.ww. Piritramide.xx. Proheptazine.yy. Properidine.zz. Propiram.aaa. Racemoramide.bbb. Thiofentanyl (N‑phenyl‑N‑[1‑(2‑thienyl)ethyl‑4‑piperidinyl]‑propanamide.ccc. Tilidine.ddd. Trimeperidine.(2) Any of the following opium derivatives, including their salts, isomers, and salts of isomers, unless specifically excepted, or listed in another schedule, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. Acetorphine.b. Acetyldihydrocodeine.c. Benzylmorphine.d. Codeine methylbromide.e. Codeine‑N‑Oxide.f. Cyprenorphine.g. Desomorphine.h. Dihydromorphine.i. Etorphine (except hydrochloride salt).j. Heroin.k. Hydromorphinol.l. Methyldesorphine.m. Methyldihydromorphine.n. Morphine methylbromide.o. Morphine methylsulfonate.p. Morphine‑N‑Oxide.q. Myrophine.r. Nicocodeine.s. Nicomorphine.t. Normorphine.u. Pholcodine.v. Thebacon.w. Drotebanol.(3) Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers, unless specifically excepted, or listed in another schedule, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. 3, 4‑methylenedioxyamphetamine.b. 5‑methoxy‑3, 4‑methylenedioxyamphetamine.c. 3, 4‑Methylenedioxymethamphetamine (MDMA).d. 3,4‑methylenedioxy‑N‑ethylamphetamine (also known as N‑ethyl‑ alpha‑methyl‑3,4‑(methylenedioxy)phenethylamine, N‑ethyl MDA, MDE, and MDEA).dd. Alpha-Methyltryptamine.e. N‑hydroxy‑3,4‑methylenedioxyamphetamine (also known as N‑ hydroxy‑alpha‑methyl‑3,4‑(methylenedioxy)phenethylamine, and N‑hydroxy MDA).ee. 5-Methoxy-n-diisopropyltryptamine.f. 3, 4, 5‑trimethoxyamphetamine.g. Alpha‑ethyltryptamine. Some trade or other names: etryptamine, Monase, alpha‑ethyl‑1H‑indole‑3‑ethanamine, 3‑(2‑aminobutyl) indole, alpha‑ET, and AET.h. Bufotenine.i. Diethyltryptamine.j. Dimethyltryptamine.k. 4‑methyl‑2, 5‑dimethoxyamphetamine.l. Ibogaine.m. Lysergic acid diethylamide.n. Mescaline.o. Peyote, meaning all parts of the plant presently classified botanically as Lophophora Williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seed or extracts.p. N‑ethyl‑3‑piperidyl benzilate.q. N‑methyl‑3‑piperidyl benzilate.r. Psilocybin.s. Psilocin.t. 2, 5‑dimethoxyamphetamine.u. 2, 5‑dimethoxy‑4‑ethylamphetamine. Some trade or other names: DOET.v. 4‑bromo‑2, 5‑dimethoxyamphetamine.w. 4‑methoxyamphetamine.x. Ethylamine analog of phencyclidine. Some trade or other names: N‑ethyl‑1‑phenylcyclohexylamine, (1‑phenylcyclohexyl) ethylamine, N‑(1‑phenylcyclohexyl) ethylamine, cyclohexamine, PCE.y. Pyrrolidine analog of phencyclidine. Some trade or other names: 1‑(1‑phenylcyclohexyl)‑pyrrol idine, PCPy, PHP.z. Thiophene analog of phencyclidine. Some trade or other names: 1‑[1‑(2‑thienyl)‑cyclohexyl]‑piperidine, 2‑thienyl analog of phencyclidine, TPCP, TCP.aa. 1‑[1‑(2‑thienyl)cyclohexyl]pyrrolidine; Some other names: TCPy.bb. Parahexyl.cc. 4‑Bromo‑2, 5‑Dimethoxyphenethylamine.(4) Any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, unless specifically excepted or unless listed in another schedule:a. Mecloqualone.b. Methaqualone.c. Gamma hydroxybutyric acid; Some other names: GHB, gamma‑ hydroxybutyrate, 4‑hydroxybutyrate, 4‑hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate.(5) Stimulants.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:a. Aminorex. Some trade or other names: aminoxaphen; 2‑amino‑5‑ phenyl‑2‑oxazoline; or 4,5‑dihydro‑5‑phenly‑2‑oxazolamine.b. Cathinone. Some trade or other names: 2‑amino‑1‑phenyl‑1‑propanone, alpha‑aminopropiophenone, 2‑aminopropiophenone, and norephedrone.c. Fenethylline.d. Methcathinone. Some trade or other names: 2‑(methylamino)propiophenone, alpha‑(methylamino)propiophenone, 2‑(methylamino)‑1‑ phenylpropan‑1‑one, alpha‑N‑methylaminopropiophenone, monomethylproprion, ephedrone, N‑methylcathinone, methylcathinone, AL‑ 464, AL‑422, AL‑463, and UR1432.e. (+/‑)cis‑4‑methylaminorex [(+/‑)cis‑4,5‑dihydro‑4‑methyl‑5‑phenyl‑2‑oxazolamine] (also known as 2‑amino‑4‑methyl‑5‑phenyl‑2‑oxazoline).f. N,N‑dimethylamphetamine. Some other names: N,N,alpha‑trimethylbenzeneethaneamine; N,N,alpha‑trimethylphenethylamine.g. N‑ethylamphetamine.h. 4-methylmethcathinone (also known as mephedrone).i. 3,4-Methylenedioxypyrovalerone (also known as MDPV).j. A compound, other than buproprion, that is structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents; (ii) by substitution at the 3-position with an alkyl substituent; or (iii) by substitution at the nitrogen atom with alkyl or diakyl groups or by inclusion of the nitrogen atom in a cyclic structure. Note: The 2011 technical corrections bill, S.L. 2011-326, also added subsections (5)(h) and (5)(i) as follows:h. N-Benzylpiperazine.i. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine.

However, an earlier 2011 session law, S.L. 2011-12, had already added different controlled substances in new subsections (h) and (i) as reflected above. The revisor of statutes has informed the author that subsections (5)(h) and (5)(i), as added by the technical corrections bill, will be denominated subsections (5)(k) and (5)(l) in the codified statutes.

§90‑89.1. Treatment of controlled substance analogues.A controlled substance analogue shall, to the extent intended for human consumption, be treated for the purposes of any State law as a controlled substance in Schedule I.

§90‑90. Schedule II controlled substances.This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a high potential for abuse; currently accepted medical use in the United States, or currently accepted medical use with severe restrictions; and the abuse of the substance may lead to severe psychic or physical dependence. The following controlled substances are included in this schedule:(1) Any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, unless specifically excepted or unless listed in another schedule:a. Opium and opiate, and any salt, compound, derivative, or preparation of opium and opiate, excluding apomorphine, nalbuphine, dextrorphan, naloxone, naltrexone and nalmefene, and their respective salts, but including the following:1. Raw opium.2. Opium extracts.3. Opium fluid extracts.4. Powdered opium.5. Granulated opium.6. Tincture of opium.7. Codeine.8. Ethylmorphine.9. Etorphine hydrochloride.10. Hydrocodone.11. Hydromorphone.12. Metopon.13. Morphine.14. Oxycodone.15. Oxymorphone.16. Thebaine.17. Dihydroetorphine.b. Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph 1 of this subdivision, except that these substances shall not include the isoquinoline alkaloids of opium.c. Opium poppy and poppy straw.d. Cocaine and any salt, isomer, salts of isomers, compound, derivative, or preparation thereof, or coca leaves and any salt, isomer, salts of isomers, compound, derivative, or preparation of coca leaves, or any salt, isomer, salts of isomers, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocanized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.e. Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy).(2) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation unless specifically exempted or listed in other schedules:a. Alfentanil.aa. Tapentatol.b. Alphaprodine.c. Anileridine.d. Bezitramide.e. Carfentanil.f. Dihydrocodeine.g. Diphenoxylate.h. Fentanyl.i. Isomethadone.j. Levo‑alphacetylmethadol. Some trade or other names: levo‑alpha‑acetylmethadol, levomethadyl acetate, or LAAM.k. Levomethorphan.l. Levorphanol.m. Metazocine.n. Methadone.o. Methadone—Intermediate, 4‑cyano‑2‑dimethylamino‑4, 4‑ diphenyl butane.p. Moramide—Intermediate, 2‑methyl‑3‑morpholino‑1, 1‑diphenyl‑propane‑carboxylic acid.q. Pethidine.r. Pethidine—Intermediate – A, 4‑cyano‑1‑methyl‑4‑phenylpiperidine.s. Pethidine—Intermediate – B, ethyl‑4‑phenylpiperidine‑4‑carboxylate.t. Pethidine—Intermediate – C, 1‑methyl‑4‑phenylpiperidine‑4‑carboxylic acid.u. Phenazocine.v. Piminodine.w. Racemethorphan.x. Racemorphan.y. Remifentanil.z. Sufentanil.(3) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system unless specifically exempted or listed in another schedule:a. Amphetamine, its salts, optical isomers, and salts of its optical isomers.b. Phenmetrazine and its salts.c. Methamphetamine, including its salts, isomers, and salts of isomers.d. Methylphenidate.e. Phenylacetone. Some trade or other names: Phenyl‑2‑propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.f. Lisdexamfetamine, including its salts, isomers, and salts of isomers.(4) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, unless specifically exempted by the Commission or listed in another schedule:a. Amobarbitalb. Glutethimidec. Repealed by Session Laws 1983, c. 695, s. 2.d. Pentobarbitale. Phencyclidinef. Phencyclidine immediate precursors:1. 1‑Phenylcyclohexylamine2. 1‑Piperidinocyclohexanecarbonitrile (PCC)g. Secobarbital.(5) Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers, unless specifically excepted, or listed in another schedule, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. Repealed by Session Laws 2001‑233, s. 2(a).b. Nabilone [Another name for nabilone: (+/‑)‑trans‑3‑(1,1‑dimethylheptyl) ‑6,6a,7,8,10,10a‑hexahyd ro‑1‑hydroxy‑6, 6‑dimethyl‑9H‑dibenzo[b,d]pyran‑9‑one].

§90‑91. Schedule III controlled substances.This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a potential for abuse less than the substances listed in Schedules I and II; currently accepted medical use in the United States; and abuse may lead to moderate or low physical dependence or high pyschological dependence. The following controlled substances are included in this schedule:(a) Repealed by Session Laws 1973, c. 540, s. 5.(b) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system unless specifically exempted or listed in another schedule:1. Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid.2. Chlorhexadol.3. Repealed by Session Laws 1993, c. 319, s. 5.4. Lysergic acid.5. Lysergic acid amide.6. Methyprylon.7. Sulfondiethylmethane.8. Sulfonethylmethane.9. Sulfonmethane.9a. Tiletamine and zolazepam or any salt thereof. Some trade or other names for tiletamine‑zolazepam combination product: Telazol. Some trade or other names for tiletamine: 2‑(ethylamino)‑2‑(2‑thienyl)‑cyclohexanone. Some trade or other names for zolazepam: 4‑(2‑fluorophenyl)‑6,8‑dihydro‑1,3,8‑trimethylpyrazolo‑[3,4‑e] [1,4]‑diazepin‑7(1H)‑one. flupyrazapon.10. Any compound, mixture or preparation containing(i) Amobarbital.(ii) Secobarbital.(iii) Pentobarbital. or any salt thereof and one or more active ingredients which are not included in any other schedule.11. Any suppository dosage form containing(i) Amobarbital.(ii) Secobarbital.(iii) Pentobarbital. or any salt of any of these drugs and approved by the federal Food and Drug Administration for marketing as a suppository.12. Ketamine.(c) Nalorphine.(d) Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof unless specifically exempted or listed in another schedule:1. Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit with an equal or greater quantity of an isoquinoline alkaloid of opium.2. Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.3. Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit with a four‑fold or greater quantity of an isoquinoline alkaloid of opium.4. Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.5. Not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.6. Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.7. Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.8. Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.(e) Any compound, mixture or preparation containing limited quantities of the following narcotic drugs, which shall include one or more active, nonnarcotic, medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:1. Paregoric, U.S.P.; provided, that no person shall purchase or receive by any means whatsoever more than one fluid ounce of paregoric within a consecutive 24‑hour period, except on prescription issued by a duly licensed physician.(f) Paregoric, U.S.P., may be dispensed at retail as permitted by federal law or administrative regulation without a prescription only by a registered pharmacist and no other person, agency or employee may dispense paregoric, U.S.P., even if under the direct supervision of a pharmacist.(g) Notwithstanding the provisions of G.S. 90‑91(f), after the pharmacist has fulfilled his professional responsibilities and legal responsibilities required of him in this Article, the actual cash transaction, credit transaction, or delivery of paregoric, U.S.P., may be completed by a nonpharmacist. A pharmacist may refuse to dispense a paregoric, U.S.P., substance until he is satisfied that the product is being obtained for medicinal purposes only.(h) Paregoric, U.S.P., may only be sold at retail without a prescription to a person at least 18 years of age. A pharmacist must require every retail purchaser of a paregoric, U.S.P., substance to furnish suitable identification, including proof of age when appropriate, in order to purchase paregoric, U.S.P. The name and address obtained from such identification shall be entered in the record of disposition to consumers.(i) The Commission may by regulation except any compound, mixture, or preparation containing any stimulant or depressant substance listed in paragraphs (a)1 and (a)2 of this schedule from the application of all or any part of this Article if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system; and if the ingredients are included therein in such combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.(j) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of said isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, unless specifically excluded or listed in some other schedule.1. Benzphetamine.2. Chlorphentermine.3. Clortermine.4. Repealed by Session Laws 1987, c. 412, s. 10.5. Phendimetrazine.(k) Anabolic steroids. The term “anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, including, but not limited to, the following:1. Methandrostenolone,2. Stanozolol,3. Ethylestrenol,4. Nandrolone phenpropionate,5. Nandrolone decanoate,6. Testosterone propionate,7. Chorionic gonadotropin,8. Boldenone,9. Chlorotestosterone (4‑chlorotestosterone),10. Clostebol,11. Dehydrochlormethyltestosterone,12. Dibydrostestosterone (4‑dihydrotestosterone),13. Drostanolone,14. Fluoxymesterone,15. Formebulone (formebolone),16. Mesterolene,17. Methandienone,18. Methandranone,19. Methandriol,20. Methenolene,21. Methyltestosterone,22. Mibolerone,23. Nandrolene,24. Norethandrolene,25. Oxandrolone,26. Oxymesterone,27. Oxymetholone,28. Stanolone,29. Testolactone,30. Testosterone,31. Trenbolone, and32. Any salt, ester, or isomer of a drug or substance described or listed in this subsection, if that salt, ester, or isomer promotes muscle growth. Except such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for such administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subsection.(l) Repealed by Session Laws 2001‑233, s. 3(a).(m) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act.(n) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product. [Some other names: (6aR‑trans), ‑6a,7,8,10a‑tetrahydro‑6,6,9‑trimethyl‑3‑pentyl‑6H‑dibenzo [b,d]pyran‑1‑o1 or (‑)‑delta‑9‑(trans)‑tetrahydrocannabinol].

§90‑92. Schedule IV controlled substances.(a) This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a low potential for abuse relative to the substances listed in Schedule III of this Article; currently accepted medical use in the United States; and limited physical or pyschological dependence relative to the substances listed in Schedule III of this Article. The following controlled substances are included in this schedule:(1) Depressants.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. Alprazolam.b. Barbital.c. Bromazepam.d. Camazepam.e. Chloral betaine.f. Chloral hydrate.g. Chlordiazepoxide.h. Clobazam.i. Clonazepam.j. Clorazepate.k. Clotiazepam.l. Cloxazolam.m. Delorazepam.n. Diazepam.o. Estazolam.p. Ethchlorvynol.q. Ethinamate.r. Ethyl loflazepate.s. Fludiazepam.t. Flunitrazepam.u. Flurazepam.v. Repealed by Session Laws 2000, c. 140, s. 92.2(c).w. Halazepam.x. Haloxazolam.y. Ketazolam.z. Loprazolam.aa. Lorazepam.bb. Lormetazepam.cc. Mebutamate.dd. Medazepam.ee. Meprobamate.ff. Methohexital.gg. Methylphenobarbital (mephobarbital).hh. Midazolam.ii. Nimetazepam.jj. Nitrazepam.kk. Nordiazepam.ll. Oxazepam.mm. Oxazolam.nn. Paraldehyde.oo. Petrichloral.pp. Phenobarbital.qq. Pinazepam.rr. Prazepam.ss. Quazepam.tt. Temazepam.uu. Tetrazepam.vv. Triazolam.ww. Zolpidem.xx. Zaleplon.(2) Any material, compound, mixture, or preparation which contains any of the following substances, including its salts, or isomers and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:a. Fenfluramine.b. Pentazocine.(3) Stimulants.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. Diethylpropion.b. Mazindol.c. Pemoline (including organometallic complexes and chelates thereof).d. Phentermine.e. Cathine.f. Fencamfamin.g. Fenproporex.h. Mefenorex.i. Sibutramine.j. Modafinil.(4) Other Substances.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:a. Dextropropoxyphene (Alpha‑(plus)‑4‑dimethylamino‑1, 2‑diphenyl‑3‑methyl‑2‑propionoxybutane).b. Pipradrol.c. SPA ((‑)‑1‑dimethylamino‑1, 2‑diphenylethane).d. Butorphanol.(5) Narcotic Drugs.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:a. Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.b. Buprenorphine.(b) The Commission may by regulation except any compound, mixture, or preparation containing any stimulant or depressant substance listed in this schedule from the application of all or any part of this Article if the compound, mixture, or preparation contains one or more active, nonnarcotic, medicinal ingredients not having a stimulant or depressant effect on the central nervous system; provided, that such admixtures shall be included therein in such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse of the substances which do have a stimulant or depressant effect on the central nervous system.

§90‑93. Schedule V controlled substances.(a) This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a low potential for abuse relative to the substances listed in Schedule IV of this Article; currently accepted medical use in the United States; and limited physical or psychological dependence relative to the substances listed in Schedule IV of this Article. The following controlled substances are included in this schedule:(1) Any compound, mixture or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic alone:a. Not more than 200 milligrams of codeine or any of its salts per 100 milliliters or per 100 grams.b. Not more than 100 milligrams of dihydrocodeine or any of its salts per 100 milliliters or per 100 grams.c. Not more than 100 milligrams of ethylmorphine or any of its salts per 100 milliliters or per 100 grams.d. Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.e. Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.f. Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.(2) Repealed by Session Laws 1985, c. 172, s. 9.(3) Stimulants.—Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:a. Repealed by Session Laws 1993, c. 319, s. 7.b. Pyrovalerone.(b) A Schedule V substance may be sold at retail without a prescription only by a registered pharmacist and no other person, agent or employee may sell a Schedule V substance even if under the direct supervision of a pharmacist.(c) Notwithstanding the provisions of G.S. 90‑93(b), after the pharmacist has fulfilled the responsibilities required of him in this Article, the actual cash transaction, credit transaction, or delivery of a Schedule V substance, may be completed by a nonpharmacist. A pharmacist may refuse to sell a Schedule V substance until he is satisfied that the product is being obtained for medicinal purposes only.(d) A Schedule V substance may be sold at retail without a prescription only to a person at least 18 years of age. The pharmacist must require every retail purchaser of a Schedule V substance to furnish suitable identification, including proof of age when appropriate, in order to purchase a Schedule V substance. The name and address obtained from such identification shall be entered in the record of disposition to consumers.

§90‑94. Schedule VI controlled substances.This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that such substance comes within this schedule, the Commission shall find: no currently accepted medical use in the United States, or a relatively low potential for abuse in terms of risk to public health and potential to produce psychic or physiological dependence liability based upon present medical knowledge, or a need for further and continuing study to develop scientific evidence of its pharmacological effects.The following controlled substances are included in this schedule:(1) Marijuana.(2) Tetrahydrocannabinols. (3) Synthetic cannabinoids. – Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:a. Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Some trade or other names: JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212.b. Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.c. Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Another name: JWH-307.d. Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.e. Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Some trade or other names: SR-18, RCS-8, JWH-250, JWH-203.f. Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Some trade or other names: CP 47,497 (and homologues), cannabicyclohexanol.g. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Some trade or other names: AM-694, Pravadoline (WIN 48,098), RCS-4.h. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone. Some trade or other names: WIN 55,212-2.i. (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl) – 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370. Some trade or other names: HU-210.

§90-95. Violations; penalties.(a) Except as authorized by this Article, it is unlawful for any person:(1) To manufacture, sell or deliver, or possess with intent to manufacture, sell or deliver, a controlled substance;(2) To create, sell or deliver, or possess with intent to sell or deliver, a counterfeit controlled substance;(3) To possess a controlled substance.(b) Except as provided in subsections (h) and (i) of this section, any person who violates G.S. 90-95(a)(1) with respect to:(1) A controlled substance classified in Schedule I or II shall be punished as a Class H felon, except as follows: (i) the sale of a controlled substance classified in Schedule I or II shall be punished as a Class G felony, and (ii) the manufacture of methamphetamine shall be punished as provided by subdivision (1a) of this subsection.(1a) The manufacture of methamphetamine shall be punished as a Class C felony unless the offense was one of the following: packaging or repackaging methamphetamine, or labeling or relabeling the methamphetamine container. The offense of packaging or repackaging methamphetamine, or labeling or relabeling the methamphetamine container shall be punished as a Class H felony.(2) A controlled substance classified in Schedule III, IV, V, or VI shall be punished as a Class I felon, except that the sale of a controlled substance classified in Schedule III, IV, V, or VI shall be punished as a Class H felon. The transfer of less than 5 grams of marijuana or less than 2.5 grams of a synthetic cannabinoid or any mixture containing such substance for no remuneration shall not constitute a delivery in violation of G.S. 90-95(a)(1).(c) Any person who violates G.S. 90-95(a)(2) shall be punished as a Class I felon.(d) Except as provided in subsections (h) and (i) of this section, any person who violates G.S. 90-95(a)(3) with respect to: (1) A controlled substance classified in Schedule I shall be punished as a Class I felon. However, if the controlled substance is MDPV and the quantity of the MDPV is 1 gram or less, the violation shall be punishable as a Class 1 misdemeanor.(2) A controlled substance classified in Schedule II, III, or IV shall be guilty of a Class 1 misdemeanor. If the controlled substance exceeds four tablets, capsules, or other dosage units or equivalent quantity of hydromorphone or if the quantity of the controlled substance, or combination of the controlled substances, exceeds one hundred tablets, capsules or other dosage units, or equivalent quantity, the violation shall be punishable as a Class I felony. If the controlled substance is methamphetamine, amphetamine, phencyclidine, or cocaine and any salt, isomer, salts of isomers, compound, derivative, or preparation thereof, or coca leaves and any salt, isomer, salts of isomers, compound, derivative, or preparation of coca leaves, or any salt, isomer, salts of isomers, compound, derivative or preparation thereof which is chemically equivalent or identical with any of these substances (except decocanized coca leaves or any extraction of coca leaves which does not contain cocaine or ecgonine), the violation shall be punishable as a Class I felony.(3) A controlled substance classified in Schedule V shall be guilty of a Class 2 misdemeanor;(4) A controlled substance classified in Schedule VI shall be guilty of a Class 3 misdemeanor, but any sentence of imprisonment imposed must be suspended and the judge may not require at the time of sentencing that the defendant serve a period of imprisonment as a special condition of probation. If the quantity of the controlled substance exceeds one-half of an ounce (avoirdupois) of marijuana, 7 grams of a synthetic cannabinoid or any mixture containing such substance, or one-twentieth of an ounce (avoirdupois) of the extracted resin of marijuana, commonly known as hashish, the violation shall be punishable as a Class 1 misdemeanor. If the quantity of the controlled substance exceeds one and one-half ounces (avoirdupois) of marijuana, 21 grams of a synthetic cannabinoid or any mixture containing such substance, or three-twentieths of an ounce (avoirdupois) of the extracted resin of marijuana, commonly known as hashish, or if the controlled substance consists of any quantity of synthetic tetrahydrocannabinols or tetrahydrocannabinols isolated from the resin of marijuana, the violation shall be punishable as a Class I felony.(d1) (1) Except as authorized by this Article, it is unlawful for any person to:a. Possess an immediate precursor chemical with intent to manufacture a controlled substance; or b. Possess or distribute an immediate precursor chemical knowing, or having reasonable cause to believe, that the immediate precursor chemical will be used to manufacture a controlled substance. Any person who violates this subsection shall be punished as a Class H felon, unless the immediate precursor is one that can be used to manufacture methamphetamine.(2) Except as authorized by this Article, it is unlawful for any person to:a. Possess an immediate precursor chemical with intent to manufacture methamphetamine; or b. Possess or distribute an immediate precursor chemical knowing, or having reasonable cause to believe, that the immediate precursor chemical will be used to manufacture methamphetamine.Any person who violates this subsection shall be punished as a Class F felon.(d2) The immediate precursor chemicals to which subsection (d1) and (d1a) of this section applies are those immediate precursor chemicals designated by the Commission pursuant to its authority under G.S. 90-88, and the following (until otherwise specified by the Commission): (1) Acetic anhydride.(2) Acetone.(3) Anhydrous ammonia.(4) Anthranilic acid.(5) Benzyl chloride.(6) Benzyl cyanide.(7) 2‑Butanone (Methyl Ethyl Ketone).(8) Chloroephedrine.(9) Chloropseudoephedrine.(10) D‑lysergic acid.(11) Ephedrine.(12) Ergonovine maleate.(13) Ergotamine tartrate.(14) Ethyl ether.(15) Ethyl Malonate.(16) Ethylamine.(17) Gamma‑butyrolactone.(18) Hydrochloric Acid.(19) Iodine.(20) Isosafrole.(21) Lithium.(22) Malonic acid.(23) Methylamine.(24) Methyl Isobutyl Ketone.(25) N‑acetylanthranilic acid.(26) N‑ethylephedrine.(27) N‑ethylepseudoephedrine.(28) N‑methylephedrine.(29) N‑methylpseudoephedrine.(30) Norpseudoephedrine.(31) Phenyl‑2‑propane.(32) Phenylacetic acid.(33) Phenylpropanolamine.(34) Piperidine.(35) Piperonal.(36) Propionic anhydride.(37) Pseudoephedrine.(38) Pyrrolidine.(39) Red phosphorous.(40) Safrole.(41) Sodium.(42) Sulfuric Acid.(43) Tetrachloroethylene.(44) Thionylchloride.(45) Toluene.(e) The prescribed punishment and degree of any offense under this Article shall be subject to the following conditions, but the punishment for an offense may be increased only by the maximum authorized under any one of the applicable conditions:(1), (2) Repealed by Session Laws 1979, c. 760, s. 5.(3) If any person commits a Class 1 misdemeanor under this Article and if he has previously been convicted for one or more offenses under any law of North Carolina or any law of the United States or any other state, which offenses are punishable under any provision of this Article, he shall be punished as a Class I felon. The prior conviction used to raise the current offense to a Class I felony shall not be used to calculate the prior record level;(4) If any person commits a Class 2 misdemeanor, and if he has previously been convicted for one or more offenses under any law of North Carolina or any law of the United States or any other state, which offenses are punishable under any provision of this Article, he shall be guilty of a Class 1 misdemeanor. The prior conviction used to raise the current offense to a Class 1 misdemeanor shall not be used to calculate the prior conviction level;(5) Any person 18 years of age or over who violates G.S. 90-95(a)(1) by selling or delivering a controlled substance to a person under 16 years of age but more than 13 years of age or a pregnant female shall be punished as a Class D felon. Any person 18 years of age or over who violates G.S. 90-95(a)(1) by selling or delivering a controlled substance to a person who is 13 years of age or younger shall be punished as a Class C felon. Mistake of age is not a defense to a prosecution under this section. It shall not be a defense that the defendant did not know that the recipient was pregnant.(6) For the purpose of increasing punishment under G.S. 90-95(e)(3) and (e)(4), previous convictions for offenses shall be counted by the number of separate trials at which final convictions were obtained and not by the number of charges at a single trial;(7) If any person commits an offense under this Article for which the prescribed punishment requires that any sentence of imprisonment be suspended, and if he has previously been convicted for one or more offenses under any law of North Carolina or any law of the United States or any other state, which offenses are punishable under any provision of this Article, he shall be guilty of a Class 2 misdemeanor;(8) Any person 21 years of age or older who commits an offense under G.S. 90‑95(a)(1) on property used for a child care center, or for an elementary or secondary school or within 1,000 feet of the boundary of real property used for a child care center, or for an elementary or secondary school shall be punished as a Class E felon. For purposes of this subdivision, the transfer of less than five grams of marijuana for no remuneration shall not constitute a delivery in violation of G.S. 90‑95(a)(1). For purposes of this subdivision, a child care center is as defined in G.S. 110-86(3)a., and that is licensed by the Secretary of the Department of Health and Human Services.(9) Any person who violates G.S. 90-95(a)(3) on the premises of a penal institution or local confinement facility shall be guilty of a Class H felony. (10) Any person 21 years of age or older who commits an offense under G.S. 90-95(a)(1) on property that is a public park or within 1,000 feet of the boundary of real property that is a public park shall be punished as a Class E felon. For purposes of this subdivision, the transfer of less than five grams of marijuana for no remuneration shall not constitute a delivery in violation of G.S. 90-95(a)(1). (f) Any person convicted of an offense or offenses under this Article who is sentenced to an active term of imprisonment that is less than the maximum active term that could have been imposed may, in addition, be sentenced to a term of special probation. Except as indicated in this subsection, the administration of special probation shall be the same as probation. The conditions of special probation shall be fixed in the same manner as probation, and the conditions may include requirements for rehabilitation treatment. Special probation shall follow the active sentence. No term of special probation shall exceed five years. Special probation may be revoked in the same manner as probation; upon revocation, the original term of imprisonment may be increased by no more than the difference between the active term of imprisonment actually served and the maximum active term that could have been imposed at trial for the offense or offenses for which the person was convicted, and the resulting term of imprisonment need not be diminished by the time spent on special probation. (g) Whenever matter is submitted to the North Carolina State Bureau of Investigation Laboratory, the Charlotte, North Carolina, Police Department Laboratory or to the Toxicology Laboratory, Reynolds Health Center, Winston-Salem for chemical analysis to determine if the matter is or contains a controlled substance, the report of that analysis certified to upon a form approved by the Attorney General by the person performing the analysis shall be admissible without further authentication and without the testimony of the analyst in all proceedings in the district court and superior court divisions of the General Court of Justice as evidence of the identity, nature, and quantity of the matter analyzed. Provided, however, the provisions of this subsection may be utilized by the State only if:(1) The State notifies the defendant at least 15 days before the proceeding at which the report would be used of its intention to introduce the report into evidence under this subsection and provides a copy of the report to the defendant, and(2) The defendant fails to file a written objection with the court, with a copy to the State, at least five days before the proceeding that the defendant objects to the introduction of the report into evidence.If the defendant’s attorney of record, or the defendant if that person has no attorney, fails to file a written objection as provided in this subsection, then the report may be admitted into evidence without the testimony of the analyst. Upon filing a timely objection, the admissibility of the report shall be determined and governed by the appropriate rules of evidence.Nothing in this subsection precludes the right of any party to call any witness or to introduce any evidence supporting or contradicting the evidence contained in the report.(g1) Procedure for establishing chain of custody without calling unnecessary witnesses.—(1) For the purpose of establishing the chain of physical custody or control of evidence consisting of or containing a substance tested or analyzed to determine whether it is a controlled substance, a statement signed by each successive person in the chain of custody that the person delivered it to the other person indicated on or about the date stated is prima facie evidence that the person had custody and made the delivery as stated, without the necessity of a personal appearance in court by the person signing the statement.(2) The statement shall contain a sufficient description of the material or its container so as to distinguish it as the particular item in question and shall state that the material was delivered in essentially the same condition as received. The statement may be placed on the same document as the report provided for in subsection (g) of this section.(3) The provisions of this subsection may be utilized by the State only if:a. The State notifies the defendant at least 15 days before trial of its intention to introduce the statement into evidence under this subsection and provides the defendant with a copy of the statement, andb. The defendant fails to notify the State at least five days before trial that the defendant objects to the introduction of the statement into evidence.(4) Nothing in this subsection precludes the right of any party to call any witness or to introduce any evidence supporting or contradicting the evidence contained in the statement

Subsections (h) and (i) are not reproduced here but are reproduced under “Trafficking,” below.

Supplement 

Statute

As a result of 2017 legislation, S.L. 2017-115, sec. 2, G.S. 90-87(14a) reads:

(14a) The term “isomer” means any type of isomer, including structural, geometric, or optical isomers, and stereoisomers.

As a result of 2015 and 2016 legislation, S.L. 2015-299, sec. 2; S.L. 2016-93, sec. 6, add the following sentence at the end of subsection G.S. 90-87(16):

The term does not include industrial hemp as defined in G.S. 106-568.51, when the industrial hemp is produced and used in compliance with rules issued by the North Carolina Industrial Hemp Commission.

As a result of 2017 legislation, S.L. 2017-115, sec. 2, G.S. 90-87(17)a. reads:

a. Opium, opiate and opioid, and any salt, compound, derivative, or preparation of opium, opiate, or opioid.

2017 legislation, S.L. 2017-115, sec. 2, created a new subsection, G.S. 90-87(18a), that reads as follows:

(18a) “Opioid" means any synthetic narcotic drug having opiate like activities but is not derived from opium.

2017 legislation, S.L. 2017-74, sec. 3, added a new subsection, (26a), to G.S. 90-87 as follows:

(26a) “Targeted controlled substance” means any controlled substance included in G.S. 90-90(1) or (2) or G.S. 90-91(d).

2015 legislation, S.L. 2015-162, sec. 1, and 2017 legislation, S.L. 2017-115, sec. 3, amended G.S. 90-89 (Schedule I) so that it reads as follows:

§90-89. Schedule I controlled substances.This schedule includes the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. In determining that a substance comes within this schedule, the Commission shall find: a high potential for abuse, no currently accepted medical use in the United States, or a lack of accepted safety for use in treatment under medical supervision. The following controlled substances are included in this schedule:(1) Opiates.—Any of the following opiates or opioids, including the isomers, esters, ethers, salts and salts of isomers, esters, and ethers, unless specifically excepted, or listed in another schedule, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:a. Acetyl-alpha-methylfentanyl (N[1-(1-methyl-2-phenethyl)-4/y-piperidinyl]-N-phenylacet amide).b. Acetylmethadol.c. Repealed by Session Laws 1987, c. 412, s. 2.d. Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl/y-4/y-piperidinyl]-N-phenylpropanamide).e. Allylprodine.f. Alphacetylmethadol (except levo-alphacetylmethadol, also known as levomethadyl acetate and LAAM).g. Alphameprodine.h. Alphamethadol.i. Alpha-methylfentanyl (N-(1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl) propionalilide; 1(1-methyl-2-phenyl-ethyl)-4-(N-propanilido) piperidine).j. Benzethidine.k. Betacetylmethadol.l. Beta-hydroxfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide).m. Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-pheny lpropanamide).n. Betameprodine.o. Betamethadol.p. Betaprodine.q. Clonitazene.r. Dextromoramide.s. Diampromide.t. Diethylthiambutene.u. Difenoxin.v. Dimenoxadol.w. Dimepheptanol.x. Dimethylthiambutene.y. Dioxaphetyl butyrate.z. Dipipanone.aa. Ethylmethylthiambutene.bb. Etonitazene.cc. Etoxeridine.dd. Furethidine.ee. Hydroxypethidine.ff. Ketobemidone.gg. Levomoramide.hh. Levophenacylmorphan.ii. 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP).jj. 3-Methylfentanyl (N-[3-methyl-1-(2-Phenylethyl)-4-Pi- peridyl]-N-Phenylpropanamide).kk. 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl/y-4-piperidinyl]-N-phenylpropanamide).ll. Morpheridine.mm. Noracymethadol.nn. Norlevorphanol.oo. Normethadone.pp. Norpipanone.qq. Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phen-ethyl)-4-piperidinyl]-propanamide.rr. Phenadoxone.ss. Phenampromide.tt. 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine (PEPAP).uu. Phenomorphan.vv. Phenoperidine.ww. Piritramide.xx. Proheptazine.yy. Properidine.zz. Propiram.aaa. Racemoramide.bbb. Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide.ccc. Tilidine.ddd. Trimeperidine.eee. Acetyl Fentanyl.fff. Trans-3,4-dichloro-N-(2(dimethylamino)cyclohexyl)-N-methyl-benzamide (U47700).ggg. 3,4-dichloro-N([1(dimethylamino)cyclohexyl]methyl)benzamide; 1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine) (also known as AH-7921).hhh. 3,4-dichloro-N-([diethylamino)cyclohexyl]-N-methylbenzamide (also known as U-49900).iii. U-77891.jjj. 1-phenylethylpiperidylidene-2-(4-chlorphenyl)sulfonamide; 1-(4-nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide; 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide (also known as W-18).kkk. 1-phenylethylpiperidylidene-2-(4-chlorophenyl)sulfonamide; 4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide (also known as W-15).lll. 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (also known as MT-45).(1a) Fentanyl derivatives.—Any compounds structurally derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide (Fentanyl) by any substitution on or replacement of the phenethyl group, any substitution on the piperidine ring, any substitution on or replacement of the propanamide group, any substitution on the anilido phenyl group, or any combination of the above unless specifically excepted or listed in another schedule to include their salts, isomers, and salts of isomers. Fentanyl derivatives include, but are not limited to, the following:a. N-(1-phenylethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (also known as Furanyl Fentanyl).b. N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide (also known as Butyryl Fentanyl).c. N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide (also known as Beta-Hydroxythiofentanyl).d. N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2propenamide (also known as Acrylfentanyl).e. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide (also known as Valeryl Fentanyl).f. N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide (also known as 2-fluorofentanyl).g. N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide (also known as 3-fluorofentanyl).h. N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (also known as tetrahydrofuran fentanyl).i. N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide (also known as 4-fluoroisobutyryl fentanyl, 4-FIBF).j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide (also known as 4-fluorobutyryl fentanyl, 4-FBF).(2) Opium derivatives.—Any of the following opium derivatives, including their salts, isomers, and salts of isomers, unless specifically excepted, or listed in another schedule, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. Acetorphine.b. Acetyldihydrocodeine.c. Benzylmorphine.d. Codeine methylbromide.e. Codeine-N-Oxide.f. Cyprenorphine.g. Desomorphine.h. Dihydromorphine.i. Etorphine (except hydrochloride salt).j. Heroin.k. Hydromorphinol.l. Methyldesorphine.m. Methyldihydromorphine.n. Morphine methylbromide.o. Morphine methylsulfonate.p. Morphine-N-Oxide.q. Myrophine.r. Nicocodeine.s. Nicomorphine.t. Normorphine.u. Pholcodine.v. Thebacon.w. Drotebanol.(3) Hallucinogenic substances.—Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers, unless specifically excepted, or listed in another schedule, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:a. 3, 4-methylenedioxyamphetamine.b. 5-methoxy-3, 4-methylenedioxyamphetamine.c. 3, 4-Methylenedioxymethamphetamine (MDMA).d. 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4-(methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA).e. N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy/y-alpha-methyl-3,4-(methylenedioxy) phenethylamine, and N-hydroxy MDA).f. 3, 4, 5-trimethoxyamphetamine.g. Alpha-ethyltryptamine. Some trade or other names: etryptamine, Monase, alpha-ethyl-1H-indole-3-ethanamine, 3-(2-aminobutyl) indole, alpha-ET, and AET.h. Bufotenine.i. Diethyltryptamine.j. Dimethyltryptamine.k. 4-methyl-2, 5-dimethoxyamphetamine.l. Ibogaine.m. Lysergic acid diethylamide.n. Mescaline.o. Peyote, meaning all parts of the plant presently classified botanically as Lophophora Williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seed or extracts.p. N-ethyl-3-piperidyl benzilate.q. N-methyl-3-piperidyl benzilate.r. Psilocybin.s. Psilocin.t. 2, 5-dimethoxyamphetamine.u. 2, 5-dimethoxy-4-ethylamphetamine. Some trade or other names: DOET.v. 4-bromo-2, 5-dimethoxyamphetamine.w. 4-methoxyamphetamine.x. Ethylamine analog of phencyclidine. Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE.y. Pyrrolidine analog of phencyclidine. Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP.z. Thiophene analog of phencyclidine. Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP.aa. 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; Some other names: TCPy.bb. Parahexyl.cc. 4-Bromo-2, 5-Dimethoxyphenethylamine.dd. Alpha-Methyltryptamine.ee. 5-Methoxy-n-diisopropyltryptamine.ff. Methoxetamine (other names: MXE, 3-MeO-2-Oxo-PCE).gg. BTCP (Benzothiophenylcyclohexylpiperidine).hh. Deschloroketamine.jj. 3-MeO-PCP (3-methoxyphencyclidine).kk. 4-hydroxy-MET.ll. 4-OH-MiPT (4-hydroxy-N-methyl-N-isopropyltryptamine).mm. 5-methoxy-N-methyl-N-propyltryptamine (5-MeO-MiPT).(4) Systemic depressants.—Any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, unless specifically excepted or unless listed in another schedule:a. Mecloqualone.b. Methaqualone.c. Gamma hydroxybutyric acid; Some other names: GHB, gamma-hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate.d. Etizolam.e. Flubromazepam.f. Phenazepam.(5) Stimulants.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:a. Aminorex. Some trade or other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.b. Cathinone. Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone.c. Fenethylline.d. Methcathinone. Some trade or other names: 2-(methylamino)- propiophenone, alpha-(methylamino)propiophenone, 2-(methy- lamino)-1-phenylpropan-1-one, alpha-N-methylamino- propiophenone, monomethylproprion, ephedrone, N-methylcathinone, methylcathinone, AL-464, AL-422, AL-463, and UR1432.e. (+-)cis-4-methylaminorex [(+-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine] (also known as 2-amino-4-methyl-5-phenyl-2-oxazoline).f. N,N-dimethylamphetamine. Some other names: N,N,alpha-tri- methylbenzeneethaneamine; N,N,alpha-trimethylphenethylamine.g. N-ethylamphetamine.h. 4-methylmethcathinone (also known as mephedrone).i. 3,4-Methylenedioxypyrovalerone (also known as MDPV).j. Substituted cathinones. A compound, other than bupropion, that is structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents; (ii) by substitution at the 3-position to any extent; or (iii) by substitution at the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups or by inclusion of the nitrogen atom in a cyclic structure.k. N-Benzylpiperazine.l. 2,5—Dimethoxy-4-(n)-propylthiophenethylamine.(6) NBOMe compounds.—Any material compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation unless specifically excepted or unless listed in another schedule:a. 25B-NBOMe (2C-B-NBOMe)-2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine.b. 25C-NBOMe (2C-C-NBOMe)-2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine.c. 25D-NBOMe (2C-D-NBOMe)-2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine.d. 25E-NBOMe (2C-E-NBOMe)-2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine.e. 25G-NBOMe (2C-G-NBOMe)-2-(2,5-dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine.f. 25H-NBOMe (2C-H-NBOMe)-2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine.g. 25I-NBOMe (2C-I-NBOMe)-2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine.h. 25N-NBOMe (2C-N-NBOMe)-2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine.i. 25P-NBOMe (2C-P-NBOMe)-2-(4-Propyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine.j. 25T2-NBOMe (2C-T2-NBOMe)-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-4-(methylthio)-benzeneethanamine.k. 25T4-NBOMe (2C-T4-NBOMe)-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-4-[(1-methylethyl)thio]-benzeneethanamine.l. 25T7-NBOMe (2C-T7-NBOMe)-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-4-(propylthio)-benzeneethanamine.(7) Synthetic cannabinoids.—Any quantity of any synthetic chemical compound that (i) is a cannabinoid receptor agonist and mimics the pharmacological effect of naturally occurring substances or (ii) has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is not listed as a controlled substance in Schedules I through V, and is not an FDA-approved drug. Synthetic cannabinoids include, but are not limited to, the substances listed in sub-subdivisions a. through p. of this subdivision and any substance that contains any quantity of their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation. The following substances are examples of synthetic cannabinoids and are not intended to be inclusive of the substances included in this Schedule:a. Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Some trade or other names: JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, and WIN 55-212.b. Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.c. Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Another name: JWH-307.d. Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.e. Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Some trade or other names: SR-18, RCS-8, JWH-250, and JWH-203.f. Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Some trade or other names: CP 47,497 (and homologues), cannabicyclohexanol.g. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Some trade or other names: AM-694, Pravadoline (WIN 48,098), and RCS-4.h. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone. Some trade or other name: WIN 55,212-2.i. (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)—6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370. Some trade or other name: HU-210.j. 3-(cyclopropylmethanone) indole or 3-(cyclobutylmethanone) indole or 3-(cyclopentylmethanone) indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not further substituted on the cyclopropyl, cyclobutyl, or cyclopentyl rings to any extent. Substances in this class include, but are not limited to: UR-144, fluoro-UR-144, XLR-11, A-796,260, and A-834,735.k. Indole carboxaldehydes. Any compound structurally derived from 1H-indole-3-carboxaldehyde or 1H-indole-2-carboxaldehyde substituted in both of the following ways:1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group; and2. At the carbon of the carboxaldehyde by a phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indole ring, or (iv) anitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. Substances in this class include, but are not limited to: AB-001.l. Indole carboxamides. Any compound structurally derived from 1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in both of the following ways:1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group; and2. At the nitrogen of the carboxamide by a phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indole ring, or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. Substances in this class include, but are not limited to: SDB-001 and STS-135.m. Indole carboxylic acids. Any compound structurally derived from 1H-indole-3-carboxylic acid or 1H-indole-2-carboxylic acid substituted in both of the following ways:1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group; and2. At the nitrogen of the carboxamide by a phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indole ring, or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. Substances in this class include, but are not limited to: SDB-001 and STS-135; whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indole ring, or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. Substances in this class include, but are not limited to: PB-22 and fluoro-PB-22.n. Indazole carboxaldehydes. Any compound structurally derived from 1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde substituted in both of the following ways:1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group; and2. At the carbon of the carboxaldehyde by a phenyl, benzyl, whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indazole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indazole ring, or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring.o. Indazole carboxamides. Any compound structurally derived from 1H-indazole-3-carboxamide or 1H-indazole-2-carboxamide substituted in both of the following ways:1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group; and2. At the nitrogen of the carboxamide by a phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indazole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indazole ring, or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. Substances in this class include, but are not limited to: AKB-48, fluoro-AKB-48, APINCACA, AB-PINACA, AB-FUBINACA, ADB-FUBINACA, and ADB-PINACA.p. Indazole carboxylic acids. Any compound structurally derived from 1H-indazole-3-carboxylic acid or 1H-indazole-2-carboxylic acid substituted in both of the following ways:1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group; and2. At the hydroxyl group of the carboxylic acid by a phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; whether or not the compound is further modified to any extent in the following ways: (i) substitution to the indazole ring to any extent, (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic analog of the indazole ring, or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring.q. Carbazoles. Any compound containing a carbazole ring system with a substituent on the nitrogen atom and bearing an additional substituent at the 1, 2, or 3 position of the carbazole ring system, with a linkage connecting the ring system to the substituent:1. Where the linkage connecting the carbazole ring system to the substituent if its 1, 2, or 3 position is any of the following: Alkyl, Carbonyl, Ester, Thione, Thioester, Amino, Alkylamino, Amido, or Alkylamido.2. Where the substituent at the 1, 2, or 3 position of the carbazole ring system, disregarding the linkage, is any of the following groups: Naphthyl, Quinolinyl, Adamantyl, Phenyl, Cycloalkyl (limited to cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl), Biphenyl, Alkylamido (limited to ethylamido, propylamido, butanamido, pentamido), Benzyl, Carboxylic acid, Ester, Ether, Phenylpropylamido, or Phenylpropylamino; whether or not further substituted in either of the following ways: (i) the substituent at the 1, 2, or 3 position of the carbazole ring system, disregarding the linkage, is further substituted to any extent (ii) further substitution on the carbazole ring system to any extent. This class includes, but is not limited to, the following: MDMB CHMCZCA, EG-018, and EG-2201.r. Naphthoylnaphthalenes. Any compound structurally derived from naphthalene-1-yl-(naphthalene-1-yl) methanone with substitutions on either of the naphthalene rings to any extent. Substances in this class include, but are not limited to: CB-1313.

2017 legislation, S.L. 2017-115, sec. 4, amended G.S. 90-90(1) and (2) to read as follows:

(1) Any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, unless specifically excepted or unless listed in another schedule:a. Opium, opiate, or opioid and any salt, compound, derivative, or preparation of opium and opiate, excluding apomorphine, nalbuphine, dextrorphan, naloxone, naltrexone and nalmefene, and their respective salts, but including the following:1. Raw opium.2. Opium extracts.3. Opium fluid extracts.4. Powdered opium.5. Granulated opium.6. Tincture of opium.7. Codeine.8. Ethylmorphine.9. Etorphine hydrochloride.10. Any material, compound, mixture, or preparation which contains any quantity of hydrocodone.11. Hydromorphone.12. Metopon.13. Morphine.14. Oxycodone.15. Oxymorphone.16. Thebaine.17. Dihydroetorphine.b. Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph 1 of this subdivision, except that these substances shall not include the isoquinoline alkaloids of opium.c. Opium poppy and poppy straw.d. Cocaine and any salt, isomer, salts of isomers, compound, derivative, or preparation thereof, or coca leaves and any salt, isomer, salts of isomers, compound, derivative, or preparation of coca leaves, or any salt, isomer, salts of isomers, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocanized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.e. Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy).(2) Any of the following opiates or opioids, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation unless specifically exempted or listed in other schedules:a. Alfentanil.b. Alphaprodine.c. Anileridine.d. Bezitramide.e. Carfentanil.f. Dihydrocodeine.g. Diphenoxylate.h. Fentanyl.i. Isomethadone.j. Levo-alphacetylmethadol. Some trade or other names: levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM.k. Levomethorphan.l. Levorphanol.m. Metazocine.n. Methadone.o. Methadone—Intermediate, 4-cyano-2-dimethylamino-4, 4/y-diphenyl butane.p. Moramide—Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid.q. Pethidine.r. Pethidine—Intermediate—A, 4-cyano-1-methyl-4/y-phenylpiperidine.s. Pethidine—Intermediate—B, ethyl-4-phenylpiperidine-4-carboxylate.t. Pethidine—Intermediate—C, 1-methyl-4-phenylpiperidine-4-carboxylic acid.u. Phenazocine.v. Piminodine.w. Racemethorphan.x. Racemorphan.y. Remifentanil.z. Sufentanil.aa. Tapentadol.

2015 legislation, S.L. 2015-162, sec. 2, amended G.S. 90-90(3)d. to read as follows:

d. Methylphenidate, including its salts, isomers, and salts of its isomers.

2017 legislation, S.L. 2017-115, sec. 5, amended G.S. 90-91(d), repealing subsections (d)3. and (d)4. and adding a new subsection, (d)9., as follows:

9. Buprenorphine.

2016 and 2017 legislation, S.L. 2016-113, sec. 9; S.L. 2017-115, sec. 5, amended G.S. 90-91(k) so that it reads as follows:

(k) Anabolic steroids. The term "anabolic steroid" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, including, but not limited to, the following:1. Methandrostenolone,2. Stanozolol,3. Ethylestrenol,4. Nandrolone phenpropionate,5. Nandrolone decanoate,6. Testosterone propionate,7. Chorionic gonadotropin,8. Boldenone,8a. Boldione,9. Chlorotestosterone (4-chlorotestosterone),10. Clostebol,11. Dehydrochlormethyltestosterone,11a. Desoxymethyltesterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol) (also known as madol),12. Dibydrostestosterone (4-dihydrotestosterone),13. Drostanolone,14. Fluoxymesterone,15. Formebulone (formebolone),16. Mesterolene,17. Methandienone,18. Methandranone,19. Methandriol,19a. Methasterone,20. Methenolene,21. Methyltestosterone,22. Mibolerone,23. Nandrolene,24. Norethandrolene,25. Oxandrolone,26. Oxymesterone,27. Oxymetholone,28. Stanolone,29. Testolactone,30. Testosterone,31. Trenbolone,31a. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione), and32. Any salt, ester, or isomer of a drug or substance described or listed in this subsection, if that salt, ester, or isomer promotes muscle growth. Except such term does not include (i) an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for such administration or (ii) chorionic gonadotropin when administered by injection for veterinary use by a licensed veterinarian or the veterinarian's designated agent. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subsection.

2017 legislation, S.L. 2017-115, sec. 6, amended the list of depressants in G.S. 90-92(a)(1) to include the following additional substances:

d1. Carisoprodol.n1. Dichloralphenazone.u1. Fospropol.yy. Zopiclone.

2017 legislation, S.L. 2017-115, sec. 6; S.L. 2017-212, sec. 8.8(a), amended G.S. 90-92(a)(5) to read as follows:

(5) Narcotic Drugs.—Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:a. Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.[b. Repealed]c. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol).

Note that while S.L. 2017-212, sec. 8.8(a) appears to retain 90-92(a)(5)b., listing buprenorphine, S.L. 2017-115 repealed that provision and moved buprenorphine to G.S. 90-91(d).

2017 legislation, S.L. 2017-115, sec. 7, amended G.S. 90-93, adding a new subsection, (a)(4), as follows:

(4) Anticonvulsants.—Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:a. Ezogabine.b. Lacosamide.c. Brivaracetam.d. Pregabalin

2017 legislation, S.L. 2017-115, sec. 8, repealed G.S. 90-94(3).

As a result of 2017 legislation, S.L. 2017-115, sec. 11, G.S. 90-95(b)(2) reads as follows:

(2) A controlled substance classified in Schedule III, IV, V, or VI shall be punished as a Class I felon, except that the sale of a controlled substance classified in Schedule III, IV, V, or VI shall be punished as a Class H felon. The transfer of less than 5 grams of marijuana for no remuneration shall not constitute a delivery in violation of G.S. 90-95(a)(1).

As a result of 2017 legislation, S.L. 2017-115, sec. 11, G.S. 90-95(d)(4) reads as follows:

(4) A controlled substance classified in Schedule VI shall be guilty of a Class 3 misdemeanor, but any sentence of imprisonment imposed must be suspended and the judge may not require at the time of sentencing that the defendant serve a period of imprisonment as a special condition of probation. If the quantity of the controlled substance exceeds one-half of an ounce (avoirdupois) of marijuana or one-twentieth of an ounce (avoirdupois) of the extracted resin of marijuana, commonly known as hashish, the violation shall be punishable as a Class 1 misdemeanor. If the quantity of the controlled substance exceeds one and one-half ounces (avoirdupois) of marijuana, or three-twentieths of an ounce (avoirdupois) of the extracted resin of marijuana, commonly known as hashish, or if the controlled substance consists of any quantity of synthetic tetrahydrocannabinols or tetrahydrocannabinols isolated from the resin of marijuana, the violation shall be punishable as a Class I felony.

As a result of S.L. 2013-124; S.L. 2014-115, sec. 41(a); and S.L. 2015-32, sec. 1, G.S. 90-95(d1) reads as follows:

(d1) (1) Except as authorized by this Article, it is unlawful for any person to:a. Possess an immediate precursor chemical with intent to manufacture a controlled substance; orb. Possess or distribute an immediate precursor chemical knowing, or having reasonable cause to believe, that the immediate precursor chemical will be used to manufacture a controlled substance; orc. Possess a pseudoephedrine product if the person has a prior conviction for the possession of methamphetamine, possession with the intent to sell or deliver methamphetamine, sell or deliver methamphetamine, trafficking methamphetamine, possession of an immediate precursor chemical, or manufacture of methamphetamine. The prior conviction may be from any jurisdiction within the United States. Except where the conduct is covered under subdivision (2) of this subsection, any person who violates this subdivision shall be punished as a Class H felon.

As a result of 2015 legislation, S.L. 2015-32, sec. 1, G.S. 90-95(d2) reads as follows:

(d2) The immediate precursor chemicals to which subsection (d1) of this section applies are those immediate precursor chemicals designated by the Commission pursuant to its authority under G.S. 90-88, and the following (until otherwise specified by the Commission):(1) Acetic anhydride.(2) Acetone.(2a) Ammonium nitrate.(2b) Ammonium sulfate.(3) Anhydrous ammonia.(4) Anthranilic acid.(5) Benzyl chloride.(6) Benzyl cyanide.(7) 2 Butanone (Methyl Ethyl Ketone).(8) Chloroephedrine.(9) Chloropseudoephedrine.(10) D lysergic acid.(11) Ephedrine.(12) Ergonovine maleate.(13) Ergotamine tartrate.(13a) Ether based starting fluids.(14) Ethyl ether.(15) Ethyl Malonate.(16) Ethylamine.(17) Gamma butyrolactone.(18) Hydrochloric Acid. (Muriatic Acid).(19) Iodine.(20) Isosafrole.(21) Sources of lithium metal.(22) Malonic acid.(23) Methylamine.(24) Methyl Isobutyl Ketone.(25) N acetylanthranilic acid.(26) N ethylephedrine.(27) N ethylepseudoephedrine.(28) N methylephedrine.(29) N methylpseudoephedrine.(30) Norpseudoephedrine.(30a) Petroleum based organic solvents such as camping fuels and lighter fluids.(31) Phenyl 2 propane.(32) Phenylacetic acid.(33) Phenylpropanolamine.(34) Piperidine.(35) Piperonal.(36) Propionic anhydride.(37) Pseudoephedrine.(38) Pyrrolidine.(39) Red phosphorous.(40) Safrole.(40a) Sodium hydroxide (Lye).(41) Sources of sodium metal.(42) Sulfuric Acid.(43) Tetrachloroethylene.(44) Thionylchloride.(45) Toluene.